The 2025-2026 COVID-19 vaccines were associated with 50% estimated effectiveness against COVID-19-associated emergency ...
Changes in the vaccine advisory process in the United States have disrupted immunization guidance, which reinforces the need for independent evidence review to inform decisions regarding immunization ...
A 2020 mask mandate study used by the CDC to inform masking policy is scrutinized for flawed methodology and cherry-picked ...
Assessing Disease Control in Mismatch Repair-Proficient Colorectal Cancer With Peritoneal Metastases Treated With Immune Checkpoint Blockade-Based Combination Therapies This cohort analysis included 1 ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
Phillips is vice president for science and strategy at the COVID Collaborative and a fellow of the American College of Epidemiology. Mitchell Miglis had two months left. The Stanford University ...
A newly released staff interim report from the U.S. Senate Permanent Subcommittee on Investigations alleges that federal ...
Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk for ...
A covid vaccine study that the CDC’s chief halted this spring over methodological concerns was published Tuesday in JAMA Network Open, a leading peer-reviewed medical journal. The analysis used the ...